{"id":"lipoic-acid-and-omega-3-fatty-acids","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Mild headache"},{"rate":null,"effect":"Skin rash (lipoic acid)"}]},"_chembl":{"chemblId":"CHEMBL4298065","moleculeType":"Unknown"},"_dailymed":{"setId":"36a5c22f-86a7-436a-bb1f-a925cd6940e4","title":"OVEEZA (FOLIC ACID, METHYLCOBALAMIN, ALPHA LIPOIC ACID, UBIDECARENONE, OMEGA-3 FATTY ACIDS, ICOSAPENT, AND DOCONEXENT) CAPSULE, LIQUID FILLED [TRIVUE PHARMACEUTICALS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lipoic acid is a mitochondrial cofactor that acts as a potent antioxidant, scavenging free radicals and regenerating other antioxidants like vitamins C and E. Omega-3 fatty acids (EPA and DHA) reduce inflammatory mediators and support cellular membrane integrity. Together, they may improve metabolic function and reduce neuroinflammation.","oneSentence":"Lipoic acid and omega-3 fatty acids work together to reduce oxidative stress and inflammation through antioxidant and anti-inflammatory pathways.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T06:11:56.890Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cognitive decline and neuroprotection (investigational/marketed as supplement)"}]},"trialDetails":[{"nctId":"NCT07399743","phase":"PHASE3","title":"Effects of Lower Body Positive Pressure Therapy Versus Alpha Lipoic Acid and Omega-3 Fatty Acids on Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Badr University","startDate":"2026-02-15","conditions":"Knee Osteoarthritis","enrollment":160},{"nctId":"NCT06130228","phase":"PHASE2","title":"Nutritional Therapy in Late-onset Pompe Disease","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2024-04-01","conditions":"Pompe Disease, Muscle Loss, Obesity","enrollment":28},{"nctId":"NCT02804828","phase":"NA","title":"Mitochondrial Cocktail for Gulf War Illness","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2021-04-09","conditions":"Gulf War Syndrome, Persian Gulf Syndrome, Mitochondrial Disorders","enrollment":15},{"nctId":"NCT03866005","phase":"NA","title":"Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema","status":"UNKNOWN","sponsor":"ZeaVision, LLC","startDate":"2019-11-01","conditions":"Center-involved Diabetic Macular Edema (CI-DME)","enrollment":150},{"nctId":"NCT01381354","phase":"PHASE1","title":"Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2010-10","conditions":"Multiple Sclerosis","enrollment":38},{"nctId":"NCT00090402","phase":"PHASE1, PHASE2","title":"Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2004-04","conditions":"Alzheimer's Disease, Oxidative Stress, Dementia","enrollment":39},{"nctId":"NCT02133664","phase":"PHASE1, PHASE2","title":"Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2014-06","conditions":"Multiple Sclerosis, Cognition","enrollment":54},{"nctId":"NCT01058941","phase":"PHASE1, PHASE2","title":"Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2010-09","conditions":"Alzheimer's Disease","enrollment":67},{"nctId":"NCT01780974","phase":"PHASE1, PHASE2","title":"Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2013-04","conditions":"Treated Hypertension","enrollment":42},{"nctId":"NCT01515839","phase":"NA","title":"Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players","status":"COMPLETED","sponsor":"Amen Clinics, Inc.","startDate":"2009-05","conditions":"Traumatic Brain Injury","enrollment":100},{"nctId":"NCT00906646","phase":"PHASE3","title":"Preparation of Patients for Cardiac Surgery","status":"COMPLETED","sponsor":"Bayside Health","startDate":"2004-04","conditions":"Coronary Artery Bypass Graft Surgery, Cardiac Valve Surgery","enrollment":117}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["thiotic acid","fish oil","fish oil concentrate"],"phase":"marketed","status":"active","brandName":"lipoic acid and omega-3 fatty acids","genericName":"lipoic acid and omega-3 fatty acids","companyName":"Oregon Health and Science University","companyId":"oregon-health-and-science-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lipoic acid and omega-3 fatty acids work together to reduce oxidative stress and inflammation through antioxidant and anti-inflammatory pathways. Used for Cognitive decline and neuroprotection (investigational/marketed as supplement).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}